This is supported by the findings that p63RhoGEF gene and protein expression, which selectively responds to Ang II to activate RhoA/ROCK pathway, is reduced along with the reduction of MYPT-1 phosphorylation, while the opposite was observed in essential hypertensive patients [8,26]. The gene discussed is AGT; the disease is hypertensive disorder.